Masupirdine

Last updated

Masupirdine
Masupirdine.svg
Identifiers
  • 1-(2-bromophenyl)sulfonyl-5-methoxy-3-[(4-methylpiperazin-1-yl)methyl]indole
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
Chemical and physical data
Formula C21H24BrN3O3S
Molar mass 478.41 g·mol−1
3D model (JSmol)
  • CN1CCN(CC1)CC2=CN(C3=C2C=C(C=C3)OC)S(=O)(=O)C4=CC=CC=C4Br
  • InChI=1S/C21H24BrN3O3S/c1-23-9-11-24(12-10-23)14-16-15-25(20-8-7-17(28-2)13-18(16)20)29(26,27)21-6-4-3-5-19(21)22/h3-8,13,15H,9-12,14H2,1-2H3
  • Key:GWCYPEHWIZXYFZ-UHFFFAOYSA-N

Masupirdine is an investigational new drug that is being evaluated for the treatment of agitation in Alzheimer's dementia. [1] It is a selective 5-HT6 receptor antagonist. [2]

References

  1. "Masupirdine - Suven Life Sciences". AdisInsight. Springer Nature Switzerland AG.
  2. Nirogi R, Jayarajan P, Shinde A, Mohammed AR, Grandhi VR, Benade V, et al. (February 2023). "Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders". Biomolecules. 13 (2): 309. doi: 10.3390/biom13020309 . PMC   9953539 . PMID   36830678.